Skip to main content
Default Image

Insulin: a case study for why we need a public option in the pharmaceutical industry

The private pharmaceutical industry has every incentive to game the patent system, extract the highest prices it can, and delay the market entry of competitor drugs as long as possible. With the largest lobby in Washington and a well-oiled revolving door to its regulators — hello, Alex Azar! — large pharmaceutical companies have deftly evaded attempts to rein in their excesses. In addition to having potentially catastrophic effects on the lives of patients, profit-maximizing strategies responsible for these eye-watering price tags also result in differential pricing practices with discriminatory effects, unnecessary financial strain on the U.S. health care system, and contribute to growing corporate power over our democracy. But as one of us (D.B.) argues in a report released Tuesday, if we act now to institute a public option for pharmaceuticals, we could ensure that this terrible story is never repeated.

Publication date: 2019-09-09
Parent publication: STAT
Publication URL: https://www.statnews.com/2019/09/10/insulin-public-option-pharmaceutical-industry/

More related work

Default Image

The Democracy Collaborative and The Democracy Collaborative Workers' Union agree to fair severance package for laid-off staff

TDC and union members have agreed to a package of protections that goes well beyond the baseline severance provisions for layoffs agreed to in TDC’s union contract.

read more
Default Image

HAN Anchoring Resilience: Aligning supply chains and impact purchasing for community health summit

The Healthcare Anchor Network (HAN) convened the “Anchoring Resilience: Aligning Supply Chains and Impact Purchasing for Community Health” summit to spark collaboration in the healthcare sector around onshoring and localizing production of PPE and other supplies, with an emphasis on equity, sustainability, and supply chain resilience.

read more
Default Image

Reimagining Personal Protective Equipment (PPE) Supply Chains

The Democracy Collaborative prepared a report, created for the Healthcare Anchor Network, which details the current status of the supply chain of PPE, the market shifts caused by COVID-19, and the potential solutions to ensure capacity within US health systems for the future.

read more